Acurx Pharmaceuticals, Inc.

ACXP - Company ID 0001736243

Market cap-

Rank-

Filings232

Acurx Pharmaceuticals, Inc. has filed 232 public company documents between 2018 and 2026. The most frequent type is insider trade (51 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchACXP overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut ACXP beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow ACXP via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
424B3	424B3	3mo ago2026-05-12	-	View filing
424B3	424B3	3mo ago2026-05-12	-	View filing
EFFECT	EFFECT	4mo ago2026-05-11	-	View filing
EFFECT	EFFECT	4mo ago2026-05-11	-	View filing
10-Q	Quarterly report	4mo ago2026-05-11	2026-03-31	View filing
S-1	IPO registration	4mo ago2026-05-04	-	View filing
S-1	IPO registration	4mo ago2026-05-04	-	View filing
D	D	4mo ago2026-04-29	-	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
4	Insider trade	4mo ago2026-04-22	2026-04-20	View filing
8-K	Major company event	4mo ago2026-04-16	2026-04-15	View filing
424B5	Prospectus supplement	4mo ago2026-04-16	-	View filing
S-8	Employee stock plan	6mo ago2026-03-12	-	View filing
10-K	Annual report	6mo ago2026-03-12	2025-12-31	View filing
8-K	Major company event	6mo ago2026-03-09	2026-03-09	View filing
EFFECT	EFFECT	6mo ago2026-02-11	-	View filing
424B3	424B3	6mo ago2026-02-11	-	View filing
CORRESP	Company correspondence	7mo ago2026-02-09	-	View filing
UPLOAD	SEC correspondence	7mo ago2026-02-09	-	View filing
S-1	IPO registration	7mo ago2026-02-02	-	View filing
EFFECT	EFFECT	8mo ago2026-01-06	-	View filing
CORRESP	Company correspondence	8mo ago2026-01-02	-	View filing
S-3/A	S-3/A	8mo ago2025-12-30	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	9mo ago2025-11-14	-	View filing
10-Q	Quarterly report	10mo ago2025-11-12	2025-09-30	View filing
424B3	424B3	10mo ago2025-11-10	-	View filing
S-1	IPO registration	10mo ago2025-10-20	-	View filing
8-K	Major company event	11mo ago2025-09-22	2025-09-22	View filing
8-K	Major company event	11mo ago2025-09-19	2025-09-16	View filing
SCHEDULE 13G	SCHEDULE 13G	1y ago2025-08-14	-	View filing
10-Q	Quarterly report	1y ago2025-08-11	2025-06-30	View filing
DEFA14A	Proxy materials	1y ago2025-08-05	-	View filing
DEF 14A	Proxy statement	1y ago2025-08-04	2025-09-16	View filing
8-K	Major company event	1y ago2025-07-31	2025-07-31	View filing
PRE 14A	PRE 14A	1y ago2025-07-24	2025-09-16	View filing
EFFECT	EFFECT	1y ago2025-07-23	-	View filing
CORRESP	Company correspondence	1y ago2025-07-21	-	View filing
UPLOAD	SEC correspondence	1y ago2025-07-21	-	View filing
8-K	Major company event	1y ago2025-07-17	2025-07-17	View filing
S-1	IPO registration	1y ago2025-07-15	-	View filing
UPLOAD	SEC correspondence	1y ago2025-07-14	-	View filing
S-3	Securities registration	1y ago2025-07-09	-	View filing
D	D	1y ago2025-06-27	-	View filing
8-K	Major company event	1y ago2025-06-20	2025-06-17	View filing

Acurx Pharmaceuticals, Inc.

Similar companies to research next

Year